glp 1 microdosing for menopause What I Got Wrong About and Metabolism—and What I Recommend Now Microdosing GLP-1s Explained | Safe,
Description
Meta-analyses and large cohort studies show significant reductions in depression and anxiety scores among GLP-1 users

Indeed, its frequently reported by those taking this medication due to the appetite-suppressing effects

For example, the 3500-Calories-in-a-pound rule has been around since the 1950s, yet is not supported by any real research [20] Instead, evidence has accumulated showing that weight loss occurs in a bi-phasic manner where an initial, relatively rapid phase of weight loss occurs in the first few weeks (mostly water weight), followed by a slower, more gradual weight loss phase that lasts up to ~ a year until weight loss plateaus (mostly fat, hopefully)

doi: 10.1016/j.jhazmat.2021.126707 63 TichoALMalhotraPDudejaPKGillRKAlrefaiWA

For more on this combination, see our cagrilintide and retatrutide dosing guide